SPOTLIGHT -
Products recommendations and gender differences
Higher Dose of Oral Semaglutide More Effective for Patients With T2D
According to a recent study, the diabetes medication semaglutide is more effective as a 25 mg or 50 mg dose on its own, rather than a 14 mg add-on dose with other medications.
How Independent Pharmacists Build Their Brand In A Crowded Market
Drug Topics® is joined by Thomas W. Taylor, the owner of Williamsburg Drug, for a conversation about starting an independent pharmacy, maintaining patient relationships, and more.
Pharmacy Practitioners Describe Experiences With COVID-19 Misinformation
COVID-19 misinformation is common. A study presented at the annual APhA meeting examined how new pharmacy practitioners responded to misinformation and tried to minimize its spread.
Mental Health and CBD: What's the Latest Info
Drug Topics® is joined by Dr. Alex Capano, Chief Science Officer at Ananda Professional to discuss what CBD is used for mental health, where research should go next, and how to ensure that patients are getting effective CBD products.
First Treatment for PI3K-delta Syndrome in Patients 12 and Up Gets FDA Approval
The drug, called Leniolisib, is the first and only treatment approved in the United States for APDS, a rare primary immunodeficiency.
Study Shows Progestogen-Only Contraceptives May Increase Breast Cancer Risk
The risk of developing breast cancer was greater in women who are currently using or recently used progestogen-only contraceptives, a recent study showed.
